Future Science Group publishes 33 STM journals across three imprints: Future Medicine Ltd, Future Science Ltd and Newlands Press Ltd. Journals cover basic and clinical areas of biomedicine, and the portfolio includes titles such as Future Oncology, Nanomedicine, Epigenomics, Future Microbiology, Immunotherapy, Bioanalysis, BioTechniques and Regenerative Medicine.

This product offers read access to 17 hybrid journals along with immediate open access publishing in these titles and FSG’s 16 fully open access titles for ALL authors at participating institutions, for all article types, for a fixed fee.

Licence Fees

The FSG Read & Publish Agreement combines read access to all 17 Future Medicine and Newlands Press hybrid journals, with immediate open access publishing of the Version of Record for all articles in these titles, as well as in all 16 Newlands Press, Future Science and Future Medicine open access titles. Open access publishing is unlimited for all authors at participating institutions, on all article types under CC-BY licence terms, for a fixed price.

Pricing model

The pricing is by quotation and is bespoke to each institution based on current spend with a minimum fee based on article output.